(-)-anisomycin increases expression ISO RGD:1318175 6480464 Anisomycin results in increased expression of RORA mRNA CTD PMID:24247028 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of RORA mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of RORA mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1308419 6480464 Ethinyl Estradiol results in decreased expression of RORA mRNA CTD PMID:17351261 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of RORA mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1318175 6480464 Estradiol promotes the reaction [ESR1 protein binds to RORA promoter] CTD PMID:21359227 17beta-estradiol multiple interactions ISO RGD:1308419 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of RORA mRNA CTD PMID:26496021 17beta-estradiol affects expression ISO RGD:1318175 6480464 Estradiol affects the expression of RORA mRNA CTD PMID:22574217 17beta-estradiol decreases expression ISO RGD:1318175 6480464 Estradiol results in decreased expression of RORA mRNA CTD PMID:21632981 17beta-estradiol increases expression ISO RGD:1318175 6480464 Estradiol results in increased expression of RORA mRNA CTD PMID:21359227 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:1318175 6480464 Dihydrotestosterone promotes the reaction [AR protein binds to RORA promoter] CTD PMID:21359227 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1318175 6480464 Dihydrotestosterone results in decreased expression of RORA mRNA CTD PMID:21359227 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RORA mRNA CTD PMID:19770486 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RORA mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1308419 6480464 Tetrachlorodibenzodioxin results in increased expression of RORA mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RORA mRNA CTD PMID:24058054 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1308419 6480464 2 more ... CTD PMID:32109520 25-hydroxycholesterol affects binding ISO RGD:1318175 6480464 25-hydroxycholesterol binds to RORA protein CTD PMID:31195007 3,4-dichloroaniline increases expression ISO RGD:1318175 6480464 3, 4-dichloroaniline results in increased expression of RORA mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of RORA mRNA CTD PMID:26251327 3-phenoxybenzoic acid affects binding ISO RGD:1318175 6480464 3-phenoxybenzoic acid binds to RORA protein CTD PMID:32278787 5-aza-2'-deoxycytidine increases expression ISO RGD:1318175 6480464 Decitabine results in increased expression of RORA mRNA CTD PMID:16367923 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1318175 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of RORA mRNA] CTD PMID:21095227 6-propyl-2-thiouracil decreases expression ISO RGD:1308419 6480464 Propylthiouracil results in decreased expression of RORA mRNA CTD PMID:24780913 8-Br-cAMP decreases expression ISO RGD:1318175 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RORA mRNA CTD PMID:22079614 acrylamide decreases expression ISO RGD:1308419 6480464 Acrylamide results in decreased expression of RORA mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1318175 6480464 Aflatoxin B1 affects the expression of RORA protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1318175 6480464 Aflatoxin B1 results in decreased methylation of RORA gene, Aflatoxin B1 results in decreased methylation of RORA intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 decreases expression ISO RGD:1318175 6480464 Aflatoxin B1 results in decreased expression of RORA mRNA CTD PMID:22100608 aflatoxin B2 increases methylation ISO RGD:1318175 6480464 aflatoxin B2 results in increased methylation of RORA intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1318175 6480464 Tretinoin results in increased expression of RORA mRNA CTD PMID:23724009 arsane affects methylation ISO RGD:1318175 6480464 Arsenic affects the methylation of RORA gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1318175 6480464 Arsenic affects the methylation of RORA gene CTD PMID:25304211 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of RORA mRNA CTD PMID:15073043 arsenous acid increases expression ISO RGD:1318175 6480464 Arsenic Trioxide results in increased expression of RORA mRNA CTD PMID:26705709 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of RORA mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1318175 6480464 Benzoapyrene affects the methylation of RORA intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1318175 6480464 Benzoapyrene results in decreased methylation of RORA 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1318175 6480464 Benzoapyrene results in decreased expression of RORA mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1318175 6480464 Benzoapyrene results in increased expression of RORA mRNA CTD PMID:20064835 benzo[e]pyrene affects methylation ISO RGD:1318175 6480464 benzoepyrene affects the methylation of RORA intron CTD PMID:30157460 bifenthrin affects binding ISO RGD:1318175 6480464 bifenthrin binds to RORA protein CTD PMID:32278787 bisphenol A multiple interactions ISO RGD:1308419 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of RORA mRNA CTD PMID:26496021 bisphenol A affects expression ISO RGD:1308419 6480464 bisphenol A affects the expression of RORA mRNA CTD PMID:25181051 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of RORA mRNA CTD PMID:18974090 cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of RORA mRNA CTD PMID:30742662 cannabidiol multiple interactions EXP 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of RORA mRNA CTD PMID:30742662 carbon nanotube decreases expression ISO RGD:1318175 6480464 Nanotubes, Carbon results in decreased expression of RORA mRNA CTD PMID:25511174 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chenodeoxycholic acid affects expression ISO RGD:1318175 6480464 Chenodeoxycholic Acid affects the expression of RORA mRNA CTD PMID:31437187 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of RORA mRNA CTD PMID:23125180 chloroprene increases expression ISO RGD:1308419 6480464 Chloroprene results in increased expression of RORA mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RORA gene CTD PMID:20938992 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RORA mRNA more ... CTD PMID:17585979 , PMID:9543393 cobalt dichloride increases expression ISO RGD:1318175 6480464 cobaltous chloride results in increased expression of RORA mRNA CTD PMID:19320972 , PMID:22202117 cobalt dichloride multiple interactions ISO RGD:1318175 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RORA mRNA] CTD PMID:22202117 copper(II) sulfate increases expression ISO RGD:1318175 6480464 Copper Sulfate results in increased expression of RORA mRNA CTD PMID:19549813 cortisol increases expression ISO RGD:1318175 6480464 Hydrocortisone results in increased expression of RORA mRNA CTD PMID:21980503 cycloprothrin affects binding ISO RGD:1318175 6480464 cycloprothrin binds to RORA protein CTD PMID:32278787 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of RORA mRNA CTD PMID:19770486 cyhalothrin affects binding ISO RGD:1318175 6480464 cyhalothrin binds to RORA protein CTD PMID:32278787 deoxynivalenol increases expression ISO RGD:1318175 6480464 deoxynivalenol results in increased expression of RORA mRNA CTD PMID:24247028 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with INS1 protein] results in increased expression of RORA mRNA more ... CTD PMID:9543393 dexamethasone increases expression ISO RGD:1318175 6480464 Dexamethasone results in increased expression of RORA mRNA CTD PMID:19022236 diarsenic trioxide increases expression ISO RGD:1318175 6480464 Arsenic Trioxide results in increased expression of RORA mRNA CTD PMID:26705709 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of RORA mRNA CTD PMID:15073043 dibutyl phthalate decreases expression ISO RGD:1308419 6480464 Dibutyl Phthalate results in decreased expression of RORA mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of RORA mRNA CTD PMID:17361019 , PMID:21266533 dichloromethane decreases expression EXP 6480464 Methylene Chloride results in decreased expression of RORA mRNA CTD PMID:28392392 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of RORA mRNA CTD PMID:26934552 difenoconazole affects binding ISO RGD:1318175 6480464 difenoconazole binds to RORA protein CTD PMID:32278787 dioxygen increases expression ISO RGD:1318175 6480464 Oxygen deficiency results in increased expression of RORA mRNA CTD PMID:24236059 diuron increases expression ISO RGD:1318175 6480464 Diuron metabolite results in increased expression of RORA mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1318175 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of RORA mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1318175 6480464 Doxorubicin results in decreased expression of RORA mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1308419 6480464 Endosulfan results in increased expression of RORA mRNA CTD PMID:29391264 endrin affects binding ISO RGD:1318175 6480464 Endrin binds to RORA protein CTD PMID:32278787 enilconazole multiple interactions EXP 6480464 enilconazole binds to and results in decreased activity of RORA protein CTD PMID:22289359 ethanol increases expression ISO RGD:1318175 6480464 Ethanol results in increased expression of RORA mRNA CTD PMID:23378141 ethanol increases expression EXP 6480464 Ethanol results in increased expression of RORA mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1318175 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of RORA mRNA CTD PMID:23378141 flucythrinate affects binding ISO RGD:1318175 6480464 flucythrinate binds to RORA protein CTD PMID:32278787 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of RORA mRNA CTD PMID:28329830 flutamide decreases expression ISO RGD:1308419 6480464 Flutamide results in decreased expression of RORA mRNA CTD PMID:24136188 fluvalinate affects binding ISO RGD:1318175 6480464 fluvalinate binds to RORA protein CTD PMID:32278787 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RORA gene CTD PMID:20938992 folic acid multiple interactions ISO RGD:1318175 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of RORA mRNA CTD PMID:23378141 hexaconazole multiple interactions EXP 6480464 hexaconazole binds to and results in decreased activity of RORA protein CTD PMID:22289359 Indeno[1,2,3-cd]pyrene decreases expression EXP 6480464 indeno1 more ... CTD PMID:26377693 indole-3-methanol multiple interactions ISO RGD:1308419 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA CTD PMID:22129741 isotretinoin decreases expression ISO RGD:1318175 6480464 Isotretinoin results in decreased expression of RORA mRNA CTD PMID:20436886 ketamine increases expression ISO RGD:1308419 6480464 Ketamine results in increased expression of RORA mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RORA gene CTD PMID:20938992 leflunomide increases expression ISO RGD:1308419 6480464 leflunomide results in increased expression of RORA mRNA CTD PMID:24136188 lipopolysaccharide affects response to substance EXP 6480464 RORA protein affects the susceptibility to Lipopolysaccharides CTD PMID:28698385 lipopolysaccharide multiple interactions EXP 6480464 [RORA protein affects the susceptibility to Lipopolysaccharides] which affects the expression of IL1A more ... CTD PMID:28698385 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of RORA mRNA, Lipopolysaccharides results in increased expression of RORA protein CTD PMID:28698385 melatonin affects binding EXP 6480464 Melatonin binds to RORA protein CTD PMID:16030176 methapyrilene affects methylation ISO RGD:1318175 6480464 Methapyrilene affects the methylation of RORA intron CTD PMID:30157460 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of RORA mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO RGD:1318175 6480464 Methyl Methanesulfonate results in decreased expression of RORA mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1318175 6480464 methylmercuric chloride results in decreased expression of RORA mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-2-ethylhexylphthalate results in decreased expression of RORA mRNA CTD PMID:22401849 N-acetyl-L-cysteine multiple interactions ISO RGD:1308419 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions ISO RGD:1308419 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RORA mRNA CTD PMID:22129741 nefazodone decreases expression ISO RGD:1308419 6480464 nefazodone results in decreased expression of RORA mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1318175 6480464 Nickel results in decreased expression of RORA mRNA CTD PMID:24768652 nickel dichloride increases expression ISO RGD:1318175 6480464 nickel chloride results in increased expression of RORA mRNA CTD PMID:17312168 ozone increases expression ISO RGD:1308419 6480464 Ozone results in increased expression of RORA mRNA CTD PMID:25838073 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of RORA mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RORA mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1318175 6480464 Acetaminophen results in increased expression of RORA mRNA CTD PMID:21420995 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of RORA mRNA CTD PMID:19270015 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of RORA mRNA CTD PMID:23091169 piperonyl butoxide decreases expression ISO RGD:1308419 6480464 Piperonyl Butoxide results in decreased expression of RORA mRNA CTD PMID:22484513 pirinixic acid multiple interactions ISO RGD:1318175 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RORA mRNA CTD PMID:19710929 quercetin affects expression ISO RGD:1318175 6480464 Quercetin affects the expression of RORA mRNA CTD PMID:21632981 rotenone decreases expression ISO RGD:1308419 6480464 Rotenone results in decreased expression of RORA mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1318175 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of RORA mRNA CTD PMID:27188386 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of RORA mRNA CTD PMID:21795629 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of RORA mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1318175 6480464 sodium arsenite results in decreased expression of RORA mRNA CTD PMID:29301061 Soman increases expression ISO RGD:1308419 6480464 Soman results in increased expression of RORA mRNA CTD PMID:19281266 styrene decreases expression EXP 6480464 Styrene results in decreased expression of RORA mRNA CTD PMID:28951217 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of RORA mRNA CTD PMID:17555576 tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of RORA protein CTD PMID:20937368 tert-butyl hydroperoxide increases expression ISO RGD:1318175 6480464 tert-Butylhydroperoxide results in increased expression of RORA mRNA CTD PMID:15336504 testosterone enanthate increases expression ISO RGD:1318175 6480464 testosterone enanthate results in increased expression of RORA mRNA CTD PMID:17440010 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of RORA mRNA CTD PMID:17484886 tetraconazole multiple interactions EXP 6480464 tetraconazole binds to and results in decreased activity of RORA protein CTD PMID:22289359 thimerosal decreases expression ISO RGD:1318175 6480464 Thimerosal results in decreased expression of RORA mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1318175 6480464 trichostatin A results in increased expression of RORA mRNA CTD PMID:24935251 triflumizole multiple interactions EXP 6480464 triflumizol binds to and results in decreased activity of RORA protein CTD PMID:22289359 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of RORA mRNA CTD PMID:28973697 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of RORA mRNA, Tunicamycin results in increased expression of RORA protein CTD PMID:28698385 urethane increases expression ISO RGD:1318175 6480464 Urethane results in increased expression of RORA mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1318175 6480464 Valproic Acid affects the expression of RORA mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1308419 6480464 Valproic Acid results in decreased expression of RORA mRNA CTD PMID:29427782 valproic acid decreases methylation ISO RGD:1318175 6480464 Valproic Acid results in decreased methylation of RORA gene CTD PMID:28853863 more ... valproic acid decreases expression ISO RGD:1318175 6480464 Valproic Acid results in decreased expression of RORA mRNA CTD PMID:23179753 , PMID:27188386 valproic acid multiple interactions ISO RGD:1318175 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of RORA mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1318175 6480464 Valproic Acid results in increased expression of RORA mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:1308419 6480464 vinclozolin affects the expression of RORA mRNA CTD PMID:19015723 vinclozolin decreases methylation ISO RGD:1308419 6480464 vinclozolin results in decreased methylation of RORA gene CTD PMID:31079544 vinclozolin increases expression ISO RGD:1308419 6480464 vinclozolin results in increased expression of RORA mRNA CTD PMID:23555832 vincristine increases expression ISO RGD:1318175 6480464 Vincristine results in increased expression of RORA mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:1318175 6480464 Vitamin E results in decreased expression of RORA mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1318175 6480464 vorinostat results in decreased expression of RORA mRNA CTD PMID:27188386 zinc dichloride multiple interactions ISO RGD:1318175 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RORA mRNA] CTD PMID:22202117
